AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
A comprehensive list of world equity market indices to help you quickly locate major benchmarks and understand their regional focus.
28,379 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
The ROAD Act was billed as a catalyst for more homes, but builders, lenders, and markets show a tepid path forward as...
Memory stocks have seen a meaningful pullback. This guide breaks down whether Micron Technology, Sandisk, and Western...
Six non-AI chip makers could be poised to benefit from the AI boom, as demand broadens beyond headline AI chips. Here...
NVIDIA’s data-center momentum is accelerating as cloud capacity sold out tightens the AI compute market, pushing the ...
NEAR token surged recently, signaling renewed market interest. This guide unpacks the drivers behind the near protoco...
A notable investor exited a large Ethereum ETF and pivoted toward Bitcoin last quarter. This article explains what su...
Tesla and Google unveil a cross-industry effort aimed at reducing household energy costs through grid modernization a...
NIO’s stock surged this week on improving fundamentals and a better-than-expected outlook. This article breaks down t...
A jury finds elon musk liable for misleading investors during Twitter's $44 billion takeover, signaling a landmark ru...
Brokerages launch pilots that allow 13-year-olds to trade stocks with limited parental approval, prompting wide-rangi...
Loan Factory will origin mortgages on Pylon’s platform, cutting manual steps and accelerating closings. The move, bac...